EUVIMEDEUVIMED entdecken
Crossref

Maternal butyrate administration ameliorates fetal fatty liver and maternal metabolic alterations related to maternal obesity

Florencia Heinecke, Jeremías Pablo Flores Quiroga, Marina Labiano, Rocío Galarza, Alicia Graciela Faletti, Alicia Jawerbaum, Verónica White

Molecular and Cellular Endocrinology · 2026-10 · 620 · 112852

DOI: 10.1016/j.mce.2026.112852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2026-10. Verfasst von Florencia Heinecke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmacological and Botanical Studies (CEFyBO). Faculty of Medicine, University of Buenos Aires (UBA). CONICET, Argentina. Hauptthemen laut MEDLINE: Fatty Liver, Butyrates, Fetus, Pregnancy in Obesity. Die Arbeit nennt 59 Literaturangaben. Gefördert von: National Scientific and Technical Research Council, Agencia Nacional De Promocion Cientifica Y Tecnologica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity negatively impacts maternal and fetal metabolism, leading to the programming of metabolic disturbances in the offspring. We have previously reported numerous maternal, fetal and offspring alterations in a rat model of obesity. In this study, we administered butyrate-a short-chain fatty acid derived from gut microbiota metabolism-to obese mother rats during pregnancy and lactation in an attempt to improve maternal health and prevent the fetal features associated with the programming of fatty liver disease. The initial experimental study design comprised female Albino-Wistar rats assigned to either a control diet (C group) or a high-fat diet (FD group) to induce obesity, before being paired with control males. Pregnant rats received either butyrate (CB or FDB) or water as a vehicle (C or FD) during gestation and were euthanized at day 21 of pregnancy. The second experimental design comprised C, FD, and FDB rats that gave birth and breastfed their pups, with mothers being euthanized at the conclusion of the lactation period. At term gestation, rats with obesity exhibited increased adiposity, hepatic lipid accumulation, triglyceridemia, and circulating IL-1β. Their fetuses displayed increased body weight, liver lipid over-accumulation, and altered mRNA levels of genes involved in liver damage. Notably, butyrate administration decreased maternal circulating levels of triglycerides and IL-1β, and prevented fetal overweight status and hepatic lipid accumulation at term gestation. Importantly, butyrate exerted no effect on control rats or their fetuses. Moreover, butyrate administration ameliorated features of fatty liver disease in overweight rats at the end of lactation, further demonstrating its beneficial effects on both mothers and fetuses in this rat model of obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverButyratesFetusPregnancy in ObesityObesityAnimalsFemalePregnancyLiverRats, WistarMaleRatsDiet, High-FatInterleukin-1betaTriglyceridesLactationBody WeightAdiposityLipid Metabolism

Stichwörter der Autor:innen

ButyrateFatty liver diseaseFetusLactationMetabolic programmingPregnancy

Substanzen

ButyratesInterleukin-1betaTriglycerides

Autor:innen und Institutionen

  • Centre for Pharmacological and Botanical Studies (CEFyBO). Faculty of Medicine, University of Buenos Aires (UBA). CONICET, Argentina.
  • Universidad Autónoma de Entre Ríos, Argentina.

Förderung

  • National Scientific and Technical Research Council
  • Agencia Nacional De Promocion Cientifica Y Tecnologica

Zitieren

APA

Heinecke, F., Flores Quiroga, J. P., Labiano, M., Galarza, R., Faletti, A. G., Jawerbaum, A., & White, V. (2026). Maternal butyrate administration ameliorates fetal fatty liver and maternal metabolic alterations related to maternal obesity. Molecular and Cellular Endocrinology, 620, 112852. https://doi.org/10.1016/j.mce.2026.112852

Vancouver

Heinecke F, Flores Quiroga JP, Labiano M, Galarza R, Faletti AG, Jawerbaum A, et al. Maternal butyrate administration ameliorates fetal fatty liver and maternal metabolic alterations related to maternal obesity. Molecular and Cellular Endocrinology. 2026;620:112852. doi:10.1016/j.mce.2026.112852

BibTeX
@article{Heinecke2026,
  author = {Heinecke, Florencia and Flores Quiroga, Jeremías Pablo and Labiano, Marina and Galarza, Rocío and Faletti, Alicia Graciela and Jawerbaum, Alicia and White, Verónica},
  title = {Maternal butyrate administration ameliorates fetal fatty liver and maternal metabolic alterations related to maternal obesity},
  journal = {Molecular and Cellular Endocrinology},
  year = {2026},
  volume = {620},
  pages = {112852},
  doi = {10.1016/j.mce.2026.112852}
}
Kostenlos starten →